To seize the tremendous market opportunities and to address the unmet medical demands of valvular heart diseases, the Company has built a robust product portfolio, strategically targeting aortic valve, mitral valve, tricuspid valve, surgical valve, and procedural accessories, including our commercialized first generation TAVI product - VitaFlow® system, and other 17 pipeline products at different stages of development.
The chart below summarizes our product portfolio.
